CT-determined low skeletal muscle index predicts poor prognosis in patients with colorectal cancer
- Yue Feng 1, Xiao-Hong Cheng 2, Mei Xu 3, Rui Zhao 2, Qian-Yi Wan 2, Wei-Hua Feng 4, Hua-Tian Gan 1,5
- Yue Feng 1, Xiao-Hong Cheng 2, Mei Xu 3
- 1Department of Geriatrics and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- 2Division of Gastrointestinal Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- 3Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- 4Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- 5Laboratory of Inflammatory Bowel Disease, the Center for Inflammatory Bowel Disease, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
- 0Department of Geriatrics and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Low skeletal muscle index (SMI), identified via CT scans, indicates a poorer prognosis for colorectal cancer (CRC) patients. This association is particularly strong when combined with older age or advanced TNM stage, highlighting sarcopenia as a key prognostic factor.
Area Of Science
- Oncology
- Radiology
- Geriatrics
Background
- Sarcopenia, characterized by low skeletal muscle index (SMI), is common in colorectal cancer (CRC) patients.
- Computed tomography (CT)-based SMI assessment is a standard diagnostic tool for sarcopenia.
- Existing research presents conflicting data on the prognostic value of low SMI in CRC patients.
Purpose Of The Study
- To evaluate the prognostic significance of CT-determined low SMI in CRC patients.
- To determine if low SMI can serve as a reliable predictor of overall survival (OS) in CRC.
Main Methods
- Data from 464 CRC patients who underwent radical surgery were analyzed.
- Skeletal muscle index (SMI) was calculated from CT scans at the third lumbar vertebra.
- Univariate and multivariate analyses assessed associations between clinical factors, complications, and survival.
Main Results
- 46.7% of patients had low SMI, correlating with older age, lower BMI, higher neutrophil-to-lymphocyte ratio (NLR), and higher nutritional risk screening 2002 (NRS2002) scores.
- Low SMI was linked to increased major complications (10.9% vs. 1.3%) and longer hospital stays.
- Low SMI independently predicted major complications and was associated with significantly worse overall survival (OS) in CRC patients.
Conclusions
- CT-determined low SMI is a significant indicator of poor prognosis in colorectal cancer (CRC).
- The combination of low SMI with older age or advanced TNM stage further worsens overall survival.
- Low SMI is a valuable prognostic factor for CRC patients, especially those undergoing surgery.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

